These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9116389)

  • 1. The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued.
    Talbot JR; Fischer MM; Farley SM; Libanati C; Farley J; Tabuenca A; Baylink DJ
    Osteoporos Int; 1996; 6(6):442-7. PubMed ID: 9116389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoride therapy for osteoporosis promotes a progressive increase in spinal bone density.
    Farley SM; Libanati CR; Mariano-Menez MR; Tudtud-Hans LA; Schulz EE; Baylink DJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S37-42. PubMed ID: 2339634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal fractures during fluoride therapy for osteoporosis: relationship to spinal bone density.
    Farley SM; Wergedal JE; Farley JR; Javier GN; Schulz EE; Talbot JR; Libanati CR; Lindegren L; Bock M; Goette MM
    Osteoporos Int; 1992 Sep; 2(5):213-8. PubMed ID: 1392258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation.
    Dure-Smith BA; Farley SM; Linkhart SG; Farley JR; Baylink DJ
    J Clin Endocrinol Metab; 1996 Jan; 81(1):269-75. PubMed ID: 8550763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoride therapy for osteoporosis: a review of dose response, duration of treatment, and skeletal sites of action.
    Dure-Smith BA; Kraenzlin ME; Farley SM; Libanati CR; Schulz EE; Baylink DJ
    Calcif Tissue Int; 1991; 49 Suppl():S64-72. PubMed ID: 1933602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that fluoride therapy increases trabecular bone density in a peripheral skeletal site.
    Resch H; Libanati C; Farley S; Bettica P; Schulz E; Baylink DJ
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1622-4. PubMed ID: 8501171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of long-term fluoride and calcium therapy in correcting the deficit of spinal bone density in osteoporosis.
    Farley SM; Libanati CR; Odvina CV; Smith L; Eliel L; Wakley GK; Kilcoyne R; Schulz EE; Baylink DJ
    J Clin Epidemiol; 1989; 42(11):1067-74. PubMed ID: 2809662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoride therapy for osteoporosis: characterization of the skeletal response by serial measurements of serum alkaline phosphatase activity.
    Farley SM; Wergedal JE; Smith LC; Lundy MW; Farley JR; Baylink DJ
    Metabolism; 1987 Mar; 36(3):211-8. PubMed ID: 3821502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evidence of fluoride-induced effects on the calcaneus by measurements of broadband ultrasound attenuation (BUA)].
    Resch A; Pietschmann F; Bernecker P; Rand T; Willvonseder R; Resch H
    Rofo; 1994 Dec; 161(6):547-50. PubMed ID: 7803779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D.
    Manzke E; Rawley R; Vose G; Roginsky M; Rader JI; Baylink DJ
    Metabolism; 1977 Sep; 26(9):1005-10. PubMed ID: 895531
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
    Struys A; Snelder AA; Mulder H
    Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoride pharmacokinetics in good and poor responders to fluoride therapy.
    Kraenzlin ME; Kraenzlin C; Farley SM; Fitzsimmons RJ; Baylink DJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S49-52. PubMed ID: 2339636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
    Ringe JD; Kipshoven C; Cöster A; Umbach R
    Osteoporos Int; 1999; 9(2):171-8. PubMed ID: 10367046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients.
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Bone; 1994; 15(4):393-9. PubMed ID: 7917577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures.
    Anderson FH; Francis RM; Bishop JC; Rawlings DJ
    Age Ageing; 1997 Sep; 26(5):359-65. PubMed ID: 9351480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for the development of stress fractures during fluoride therapy for osteoporosis.
    Schnitzler CM; Wing JR; Mesquita JM; Gear AK; Robson HJ; Smyth AE
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S195-200. PubMed ID: 2339629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
    Abitbol V; Mary JY; Roux C; Soulé JC; Belaiche J; Dupas JL; Gendre JP; Lerebours E; Chaussade S;
    Aliment Pharmacol Ther; 2002 May; 16(5):919-27. PubMed ID: 11966500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.